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Abstract: 
Objectives Manganese exposure leads to diffuse cerebral metal deposition with the highest 
concentration in the globus pallidus associated with increased T1-weighted MRI signal. T1 
signal intensity in extra-pallidal basal ganglia (caudate and putamen) has not been studied in 
occupationally exposed workers. Diffusion weighted imaging is a non-invasive measure of 
neuronal damage and may provide a quantification of neurotoxicity associated with welding and 
manganese exposure. This study investigated extra-pallidal T1 basal ganglia signal intensity as a 
marker of manganese exposure and basal ganglia diffusion weighted imaging abnormalities as a 
potential marker of neurotoxicity. 
 
Methods A 3T MR case:control imaging study was performed on 18 welders and 18 age- and 
gender-matched controls. Basal ganglia regions of interest were identified for each subject. T1-
weighted intensity indices and apparent diffusion coefficients were generated for each region. 
 
Results All regional indices were higher in welders than controls (p≤0.05). Combined basal 
ganglia (ρ=0.610), caudate (ρ=0.645), anterior (ρ=0.595) and posterior putamen (ρ=0.511) 
indices were more correlated with exposure than pallidal (ρ=0.484) index. Welder apparent 
diffusion coefficient values were lower than controls for globus pallidus (p=0.03) and anterior 
putamen (p=0.004). 
 
Conclusions Welders demonstrated elevated T1 indices throughout the basal ganglia. Combined 
basal ganglia, caudate and putamen indices were more correlated with exposure than pallidal 
index suggesting more inclusive basal ganglia sampling results in better exposure markers. 
Elevated indices were associated with diffusion weighted abnormalities in the pallidum and 
anterior putamen suggesting neurotoxicity in these regions. 




Over 1 million workers in the USA weld as part of their job duties.1 Exposure to welding fume 
and its constituents, particularly manganese (Mn) may produce basal ganglia neurotoxicity 
resulting in clinical parkinsonism.2 Parkinsonism is a clinical syndrome characterised by tremor, 
rigidity, bradykinesia and postural instability.3 While an exposure–response relationship 
between Mn or welding fume and parkinsonism has not yet been determined, high levels of Mn 
exposure can result in deposition in the brain4–6 with a characteristic increased signal on T1-
weighted MR imaging in the globus pallidus.7,8 The intensity of the pallidal signal correlates 
with welding exposure9 and Mn blood levels10 but is less clearly linked with clinical 
symptomatology, including parkinsonism. In addition, the relationship between signal intensity 
and neuronal pathology is unknown. Potentially, a more sensitive T1-weighted marker could 
provide an improved marker of exposure and potentially an antecedent biomarker of Mn 
neurotoxicity prior to onset of clinical symptomatology. Such a biomarker could be a critical tool 
to investigate the neurotoxicity of metal exposures and permit screening of at-risk workers. 
Patients with cirrhosis, at risk for Mn toxicity due to impaired Mn clearance, have extra-pallidal 
T1 hyperintesities, including abnormal signal in caudate and putamen.11,12 However, extra-
pallidal deposition of Mn with subsequent T1 hyperintensities and their relationship with 
exposure have not been explored in workers with occupational exposures to Mn. Non-human 
primates demonstrate greatest Mn deposition in globus pallidus, but Mn also accumulates in 
caudate and putamen.4 Similarly, neuropathological examinations in humans with symptomatic 
clinical Mn toxicity reveal degeneration of the medial segment of the globus pallidus with less 
severe degeneration of the putamen and caudate.13 Additional evidence that welding affects 
non-pallidal basal ganglia structures comes from the observation that PET measured uptake of 
[18F]FDOPA is reduced in the caudate of asymptomatic welders.14 Together these findings 
suggest that extra-pallidal hyperintensities are likely present in occupationally exposed welders. 
Intensity measurement of these regions may prove to be improved markers of exposure and its 
relationship to clinical symptomatology. 
 
Structural T1-weighted imaging is an established marker of Mn exposure but remains limited as 
it does not provide information about function or neuropathology. Diffusion weighted (DW) and 
diffusion tensor imaging (DTI) non-invasively measure the Brownian movement of water 
molecules (diffusion) in the brain.15 The movement of water is measured in terms of the 
apparent diffusion coefficient (ADC). Changes in the ADC represent disruption in the movement 
of water secondary to changes in neuronal architecture.15 Diffusion weighted imaging (DWI) 
can easily be acquired during standard brain MRI imaging and provides detailed information 
about neuronal structural integrity. Restricted diffusion, as measured by ADC, is associated with 
the accumulation of sodium and water within a neuron leading to cytotoxic edema and neuronal 
death.16 A previous case study using DWI reported restricted diffusion in the globus pallidus of 
a patient with Mn toxicity secondary to liver failure.17 
 
Our primary hypothesis was that Mn exposure in welders would be associated with elevated T1 
signal indices in globus pallidus, caudate, anterior and posterior putamen and the intensity of the 
signal in all four regions would directly correlate with welding exposure. Our secondary 
hypothesis was that the average DWI ADC values across these basal ganglia regions would be 
reduced in areas with elevated intensity indexes indicating local neuropathological changes. 
Demonstration of pallidal and extra-pallidal DW abnormalities in Mn-exposed welders that 
correlate with T1 markers of exposure could provide a critical link in understanding the 




This study was approved by the Washington University School of Medicine Human Research 
Protection Office, and all subjects signed a written consent. Welder data are presented in 
aggregate to protect individual-subject confidentiality. Welders were recruited from two 
Midwestern shipyards and one fabrication company from April 2007 through November 2010. 
The welding processes most commonly used by these welders were flux core arc welding, 
shielded metal arc welding and gas metal arc welding mainly on carbon steel.14 For our power 
calculation, we assumed that exposed welders would have caudate and putamen indices at least 5 
points (5%) higher than unexposed controls. A sample size of 20 per group, anticipating a loss of 
two subjects per group, provided over 80% power to detect a 5% difference between welders and 
normal subjects even using an α level of 0.01 (assuming there are multiple comparisons in the 
analysis). Healthy age- and gender-matched control subjects were recruited for a 1:1; 
case:control match with the welders who had completed scans. Control subjects were community 
volunteers who were referred from our extensive regional volunteer network and were 
individually aged matched for welders ±4 years. All subjects were evaluated by a Movement 
Disorders specialist blinded to exposure status with an examination that included a Unified 
Parkinson’s Disease Rating Scale motor subsection 3 (UPDRS3), which includes objective rating 
of the cardinal features of parkinsonism-tremor, rigidity, bradykinesia and postural instability.18 
Welders were excluded from participation if they had <100 h of welding exposure or if they had 
comorbid neurological disease that affected the UPDRS3 rating. Control subjects were excluded 
if they had a total UPDRS3 score of >3 or an individual rest, postural or action tremor score of 
>1. All subjects were screened for prior drug (prescription and recreational) exposures and were 
excluded for neuroleptic or amphetamine use. Welding subjects completed a validated exposure 
questionnaire and provided blood samples for Mn levels.19 Self-reported welding days/week and 
hours/day per job were multiplied by the number of weeks held at that job. This resulted in the 
number of hours a participant welded per job. Cumulative exposure hours were calculated by 
summing the per job welding hours. Blood Mn levels were analysed with graphite furnace 
atomic spectrometry (Varian AA240; Varian, Inc., Agilent Technologies, Santa Clara, CA USA) 




Imaging was performed on a 3.0T Siemens Trio scanner (Erlangen, Germany). Structural 
anatomic scans included a T1-weighted sagittal, magnetisation-prepared rapid gradient echo 
(MPRAGE; repetition time (TR)=2400 ms; inversion time (TI)=1000 ms, echo time (TE)=3.14 
ms, flip angle=8°, 0.9×0.9×0.9 mm voxels) and a T2-weighted (T2W) fast spin echo (TR=3200 
ms, TE=469 ms, 0.9×0.9×0.9 mm). 
 
To prevent any bias in analysis, a reviewer blinded to the clinical status of the subject outlined 
volumes of interest (VOIs), including the caudate, globus pallidus, anterior and posterior 
putamen and occipital regions on individual MR images. The intensity of the signal on the T1 
weighted image in the VOI was compared by calculating an intensity index for each subject. The 
intensity index was defined as the ratio of T1 signal in the VOI to a white matter reference 
region. Regional indices were calculated from the T1 MPRAGE images as previously described 
for the pallidal index.21 
 
Intensity index = [(Left VOI+Right VOI)/(Left white matter control region+Right white matter 
control region)]×100 
Intensity indices were created for the globus pallidus, caudate, anterior putamen and posterior 
putamen using the same reference control regions. A combined basal ganglia intensity index was 
created by averaging the intensity indexes of all four VOIs. 
 
Three sets of DTI images were acquired in 25 directions, at multiple b values, using an echo 
planar imaging sequence (TR=9200 ms, TE=90 ms, 2.0 mm isotropic voxels, b values =0–1400 
s/mm2). Diffusion analysis was performed using standard log-linear regression22 with software 




Age and UPDRS3 scores were compared between the welders and control groups using Mann–
Whitney U tests. Within the welder cohort, relationships between Mn blood levels, welding 
exposure hours, regional indices and ADC values were examined with Spearman’s correlations. 
A hierarchical linear regression model was used in a series of forced entry regression models to 
examine if adding additional intensity indices to the gold standard pallidal index would improve 
the ability to predict welding exposure by comparing the additional variance explained. Repeated 
measures generalised linear modelling (GLM) analysis was used to examine the effects of 
diagnostic group and region on regional intensity indexes and ADC values. In addition, the 
interaction between diagnostic group (between-subjects variable) and region (within-subject 
variable) from the repeated measures GLM analysis was used to examine differences in the 
patterns of these variables across regions in the two groups. Post hoc Mann–Whitney U tests 
were performed to compare differences between groups for each region. The statistical software 




We screened 193 subjects with a history of welding exposure to participate in this study. Of 
subjects contacted, 20 were unable to participate due to exclusionary criteria (imbedded metal, 
exclusionary medication, unable to fit in scanner), 20 refused to participate and the remainder 
were scanned or were willing to be scanned at a future date. The scanned subjects did not differ 
significantly from the entire cohort or those who were excluded based on age, gender, race, 
tobacco use or welding hours. Those scanned were younger than those who refused (mean age 
41.0 and 54.6 years, respectively, p<0.01) but did not differ significantly on gender, race, 
tobacco use or welding hours. Of the 20 welders originally scanned, two subjects’ MRIs could 
not be analysed secondary to poor head position from scoliosis in one subject and excessive 
motion artefact in another. The remaining 18 welders with completed scans were compared with 
18 age- and gender-matched control subjects. Demographic characteristics for the two diagnostic 
categories are shown in table 1. Welders had median lifetime exposure of 9862 (IQR 2138.18–24 
719.86) welding hours and average Mn levels two times the upper limits of normal (24.15±17.6 
µg/l, normal values <10.8 µg/l). Welders demonstrated mildly elevated median UPDRS3 scores 
(6.25) despite no clinical symptoms and were different from the control group (table 1). 
UPDRS3 scores and blood Mn levels did not correlate with exposure hours or the age of the 
subject. 
Table 1 
Demographic data by diagnostic category 
 
Normal control (n=18) Welders (n=18) p Value 
Gender (female/male) 1/17 1/17 
 
Age, median in years (IQR) 37.5 (25.7–52.0) 40.5 (29.2–50.2) 0.558* 
UPDRS3 score, median (IQR) 0 (0–3) 6.25 (2.75–10.25) ≤0.001* 
*Mann–Whitney U test compared welders with normal controls. 
UPDRS3, Unified Parkinson’s Disease Rating Scale motor subsection 3. 
Repeated measures GLM analysis of the intensity indexes demonstrated a main effect of group, 
F(1,33)=13.76, p=0.001, and region, F(3,102)=894.96, p≤0.001, indicating between-subject 
differences between the two groups and within-subject differences between regions. There was 
also a strong interaction between region and group within the model, F(3,102)=6.16, p=0.001, 
indicating a different pattern of T1 intensity indices across regions in the diagnostic groups. Post 
hoc Mann–Whitney U tests revealed that intensity indices (left and right side averaged) were 
significantly higher in welders than controls for all regions (table 2). The greatest relative 







T1 intensity indices in welders and normal controls 
 
Normal control (n=18) Welders (n=18) p Value 
Pallidal index, median (IQR) 112.35 (109.59–116.16) 118.11 (115.14–123.87) 0.002* 
Caudate index, median (IQR)     86.7 (85.0–88.44)   89.10 (86.64–91.20) 0.019* 
Anterior putamen index, median (IQR)   88.58 (86.69–90.12)   91.85 (89.10–97.18) 0.005* 
Posterior putamen index, median (IQR)   96.66 (93.99–98.22)   99.59 (97.99–104.94) 0.002* 
Basal ganglia index, median (IQR)   96.55 (93.97–98.10)     99.2 (97.70–104.95) 0.002* 
*Mann–Whitney U tests compared welders to normal controls. 
 
Within the welder cohort, the combined global basal ganglia intensity index (Spearman’s 
correlation, ρ=0.610, p=0.007), caudate index (ρ=0.645, p=0.004), anterior putamen (ρ=0.595, 
p=0.009) and the posterior putamen index (ρ=0.571, p=0.013) were all correlated with exposure 
hours. All four indices were more correlated with exposure than the pallidal index (Spearman’s 
correlation ρ=0.484, p=0.042). The exposure-imaging correlations are illustrated in figure 1. 
None of the indexes were correlated with the age of either welder or control subjects. Welder 
blood Mn levels were inversely correlated with caudate index (ρ=−0.0552, p=0.012) but none of 
the other intensity indices. UPDRS3 values were not correlated with intensity indices within the 
welder or control cohort. 
 
Correlations between regional intensity indices and cumulative exposure hours. Scatter plots 
demonstrate the correlations between the globus pallidus (A), caudate (B), anterior putamen (C), 
posterior putamen (D), combined basal ganglia (E) indices and cumulative exposure hours. 
The hierarchical linear regression analysis using individual intensity indices as predictors of 
welding exposure hours within the welder group is depicted in table 3. Additional indices did 
improve the overall model but the caudate intensity index was the most predictive variable 
(β=0.485 vs pallidal index, β=0.012) and provided the only significant R2 change in the analysis. 
A separate linear regression analysis using the combined basal ganglia intensity index of welders 
revealed the combined index had an R value of 0.489 and an R2 value of 0.239 in predicting 
exposure hours. 
Table 3 
Hierarchical regression model for exposure hours using individual intensity indices 
   
Change statistics 
   
 
Model R R2 R2 change F change Significant F change 
1 0.335* 0.112 0.112 2.017 0.175 
2 0.577† 0.333 0.221 4.977 0.041 
3 0.581‡ 0.337 0.004 0.083 0.778 
4 0.583§ 0.340 0.003 0.065 0.803 
*Predictors included in model 1: pallidal index. 
†Predictors included in model 2: pallidal index, caudate index. 
‡Predictors included in model 3: pallidal index, caudate index, anterior putamen index. 
§Predictors included in model 4: pallidal index, caudate index, anterior putamen index, posterior 
putamen index. 
Repeated measures GLM analysis of the regional ADC values demonstrated a main effect of 
region, F(3,32)=40.36, p≤0.001, and group, F(3,32)=8.43, p=0.006), for the model, but group 
and the interaction between region and group was not significant indicating the pattern of 
intensity indices across regions was the same in both groups (parallel). Given the significant 
differences in the intensity values and our primary hypothesis, we performed Mann–Whitney 
tests on the individual regions as described in table 4. ADC values were lower in welders 
compared to controls in the globus pallidus (U=93.0, p=0.03) and anterior putamen (U=71.5, 
p=0.004). The ADC values of the caudate and posterior putamen were not significantly different 
from controls; however, the ADC values in all regions were lower in welders than in control 
subjects. ADC values did not correlate with exposure hours, blood Mn levels or UPDRS3 values 
within the welder cohort. 
Table 4 
ADC measurements in welders and normal controls 
 
Normal control (n=18) Welders (n=18) p Value* 
Globus pallidus, median ADC† (IQR) 0.7202 (0.6798–0.7576) 0.6844 (0.6452–0.7191) 0.03‡ 
Caudate, median ADC (IQR) 0.7216 (0.7130–0.7356) 0.7176 (0.7049–0.7406) 0.29 
Anterior putamen, median ADC (IQR) 0.7041 (0.6977–0.7138) 0.6862 (0.6788–0.7000) 0.004‡ 
Posterior putamen, median ADC (IQR) 0.7258 (0.7091–0.7333) 0.7088 (0.6821–0.7295) 0.24 
*Mann–Whitney U test compared welders to normal controls. 
†ADC values are ×10−3 mm2/s. 
‡Indicates significance at the p≤0.05 level. 
ADC, apparent diffusion coefficient. 
DISCUSSION 
While previous studies have focused on the pallidum as the primary target of Mn-induced 
neurotoxicity, our study demonstrates an increase in the intensity index in all regions of the basal 
ganglia in Mn-exposed welders. Pallidal hyperintensities in Mn toxicity have been associated 
with subsequent gliosis and neurodegeneration of the globus pallidus at autopsy.13,24 Animal 
and human studies demonstrated Mn deposition throughout the basal ganglia.4,25 Therefore, it is 
likely that the increased T1 signal in caudate and putamen indexes is also secondary to Mn 
toxicity in these extra-pallidal regions, although confirmation would require pathological studies 
in occupationally exposed welders. Clearly, future studies investigating Mn neurotoxicity should 
include investigation of extra-pallidal basal ganglia regions of interest to understand the broader 
extent of Mn-induced neurotoxicity. 
 
While the pallidal index has been previously used as the standard imaging marker of welding 
exposure; the combined basal ganglia, caudate, anterior putamen and posterior putamen intensity 
indices all showed stronger correlations with exposure hours. Of all the regional indices, the 
addition of caudate region sampling provided the greatest improvement in the hierarchical 
regression modelling of exposure hours and was the index most correlated with exposure hours. 
Alternatively, the combined basal ganglia sampling has the advantage of incorporating data from 
all four basal ganglia regions, including the traditionally used pallidal index. While the T1 
intensity indices appeared to be correlated with exposure, all the correlations were modest. This 
could be explained by the fact that welding exposure time is a relatively crude measure of Mn 
exposure and does not take into account environmental conditions, such as ventilation or the use 
of personal protective equipment. 
 
No indices correlated with the UPDRS3 or age, and the caudate index had an inverse relationship 
with Mn levels in this study. This is likely secondary to the minimal clinical signs and a narrow 
range of UPDRS3 scores within this welder cohort. Including only asymptomatic healthy 
workers improves the generalisability of these findings and minimises the risk of accidentally 
including those with confounding idiopathic Parkinson’s disease. However, examining welders 
with more parkinsonian features will be necessary to truly evaluate if there is a correlation 
between regional intensity values and clinical signs of parkinsonism as measured by the 
UPRDS3. Age was controlled for in this study by matching each welding subject to a control 
subject ±4 years. This study has a relatively small sample size for within cohort analysis, and 
therefore, we did not perform subsequent age adjustments in the statistical analysis. No studies 
have reported on a change in T1 basal ganglia intensity indices with age; however, overall grey 
matter T1 intensity has been reported to diminish with age26 and hence is unlikely to cause the 
increased signal identified in Mn exposure. The lack of a consistent association between blood 
Mn levels and the intensity indices is not surprising since Mn has a relatively short half-life in 
blood with high variability27–29 but deposition in the pallidum persists for months after 
exposure.24 In addition, it has recently been reported that Mn may bypass the blood–brain 
barrier and travel into the central nervous system via the olfactory nerve making blood levels 
even less reliable.30 
 
Whereas the TI intensity indexes were elevated in all four regions, ADC values on DWI were 
different between welders and controls only in the globus pallidus and anterior putamen. This 
small but significant restriction in the welder ADC values is interesting as this was a cohort with 
no symptomatic complaints and only minimal elevation in UPRDS3 scores. DWI may prove to 
be a reliable antecedent biomarker of Mn-induced neurotoxicity. There are only two previous 
reports on DWI/DTI in subjects with Mn exposure for comparison. The first was a single subject 
with symptomatic Mn toxicity secondary to cirrhosis who demonstrated similar, but more 
reduced ADC values in the globus pallidus.17 The second report focused on disruptions in the 
white matter connections to the cortex and did not examine the basal ganglia.31 
 
DWI studies comparing other idiopathic parkinsonian syndromes including idiopathic 
Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy found no 
differences between the ADC in basal ganglia regions of subjects with clinical parkinsonism 
diagnosed with these syndromes and healthy controls.32 However, Favrole et al33 have 
demonstrated interesting parallel findings in Wilson’s disease. Wilson’s disease is a disorder of 
copper metabolism resulting in extrapyramidal and parkinsonian symptoms secondary to metal 
deposition within the basal ganglia. Brain copper deposition in Wilson’s disease produces similar 
T1 pallidal hyperintensities to those associated with Mn exposure. In Favrole’s study, subjects 
with presymptomatic Wilson’s disease had a restricted diffusion pattern in the putamen, whereas 
patients with clinically symptomatic Wilson’s disease demonstrated increased putamen ADC 
values. Favrole et al33 hypothesised that this may represent initial gliosis or inflammation with 
secondary cytotoxic edema proceeding the degeneration and cell death usually seen at autopsy. 
Similarly, we speculate that preclinical or early Mn toxicity may be associated with restrictive 
ADC pattern in the basal ganglia that later evolves into an elevation of the ADC with the 
development of obvious clinical symptoms and more severe neuropathology. Further studies in 
symptomatic welders would be required to test this hypothesis. 
 
Pathophysiologic interpretation of this study is limited by the lack of data on the potential effect 
of a deposited paramagnetic metal like Mn in brain tissue on DWI imaging. However, in a 
previous PET imaging study with 6-[18F]fluoro-L-DOPA (FDOPA) using asymptomatic 
welders, we found a consistent reduction in FDOPA uptake in the caudate despite the absence of 
clinical parkinsonism indicating preclinical dysfunction in the nigrostriatal dopamine system.14 
This, in conjunction with similar findings in Wilson’s disease, suggests that these DWI 
abnormalities represent underlying pathology and are not just an artefact related to Mn 
deposition. In addition, with two studies now demonstrating evidence of early basal ganglia 
dysfunction using complementary but distinct functional imaging modalities, these data suggest 
that there is a period of preclinical neurotoxicity in humans with occupational Mn exposure. 
ADC values may differ between subjects older and younger than 60 years. However, ADC 
values do not appear to vary in adult subjects aged <60 years.34 As our subjects were all <60 
years old, we did not adjust for age when reporting these statistics. In addition, age over 60 years 
was associated with increases in ADC values so it is unlikely that the lower ADC values in 
welders can be explained by age when compared to a match control cohort. Of course, further 
research will be required to understand these functional changes and to establish a threshold for 
Mn neurotoxicity in the basal ganglia. 
 
Welding fumes also contain a number of elements and gases,35 and this study cannot exclude a 
contribution from other substances in welding fumes. However, Mn has been historically 
associated with parkinsonism,36 and these welders had both elevated blood Mn levels and the 
characteristic increased pallidal signal clearly documenting their metal exposure.8 Moreover, this 
study demonstrates an association between common types of welding exposures and imaging 
characteristics but does not address causation or evaluate the effects of other metals known to be 
present in welding fumes. A substantially larger population of exposed workers will be needed to 
demonstrate dose–responsive DWI and longitudinal changes in the basal ganglia. Welding 
exposure time as calculated above also does not account for work conditions or personal 
protective equipment. Unfortunately, we have limited site-specific or individualised data on the 
use of equipment such as respirators for this cohort, given the lack of required use or 
documentation of use by employers in the USA. Furthermore, eventual imaging–pathological 
correlations will be required to understand the meaning of these imaging findings. 
 
In conclusion, welders demonstrated elevated basal ganglia indices consistent with diffuse Mn 
deposition. The combined basal ganglia, caudate and putamen indices were better correlated with 
exposure than the traditionally used pallidal index, and more inclusive sampling of basal ganglia 
regions appears to result in better markers of exposures. Elevated indices were also associated 
with DW abnormalities in the globus pallidus and anterior putamen, suggesting that the increased 
signal in these regions is associated with neuronal damage. 
 
What is known about this subject 
 
Occupational manganese exposure leads to cerebral deposition of the metal, which can be 
measured on T1-weighted MRI imaging. Currently, the T1 signal intensity in the globus pallidus 
is the standard marker of manganese exposure despite being only loosely correlated with 
exposure and having no clear association with neurotoxicity. 
What this paper adds 
 
This paper demonstrates that manganese deposits more diffusely in the human brain than 
previously recognised as increased T1 signal is present throughout the basal ganglia. Combining 
multiregion measurements of the T1 signal provides a better marker of cumulative manganese 




These findings have important practical implications as improved in vivo measures of 
manganese exposure and neurotoxicity are essential in setting acceptable exposure thresholds. 
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